Switch to:
Also traded in: Germany, USA

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash-to-Debt 0.02
UHS's Cash-to-Debt is ranked lower than
99% of the 257 Companies
in the Global Medical Care industry.

( Industry Median: 0.40 vs. UHS: 0.02 )
Ranked among companies with meaningful Cash-to-Debt only.
UHS' s Cash-to-Debt Range Over the Past 10 Years
Min: 0  Med: 0.02 Max: N/A
Current: 0.02
Equity-to-Asset 0.45
UHS's Equity-to-Asset is ranked lower than
55% of the 253 Companies
in the Global Medical Care industry.

( Industry Median: 0.47 vs. UHS: 0.45 )
Ranked among companies with meaningful Equity-to-Asset only.
UHS' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.26  Med: 0.42 Max: 0.55
Current: 0.45
0.26
0.55
Interest Coverage 11.03
UHS's Interest Coverage is ranked higher than
56% of the 216 Companies
in the Global Medical Care industry.

( Industry Median: 8.17 vs. UHS: 11.03 )
Ranked among companies with meaningful Interest Coverage only.
UHS' s Interest Coverage Range Over the Past 10 Years
Min: 5.19  Med: 9.13 Max: 48.57
Current: 11.03
5.19
48.57
Piotroski F-Score: 7
Altman Z-Score: 2.55
Beneish M-Score: -2.71
WACC vs ROIC
6.19%
10.12%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating Margin % 12.88
UHS's Operating Margin % is ranked higher than
68% of the 255 Companies
in the Global Medical Care industry.

( Industry Median: 7.71 vs. UHS: 12.88 )
Ranked among companies with meaningful Operating Margin % only.
UHS' s Operating Margin % Range Over the Past 10 Years
Min: 7.91  Med: 13.04 Max: 13.93
Current: 12.88
7.91
13.93
Net Margin % 7.23
UHS's Net Margin % is ranked higher than
62% of the 256 Companies
in the Global Medical Care industry.

( Industry Median: 4.84 vs. UHS: 7.23 )
Ranked among companies with meaningful Net Margin % only.
UHS' s Net Margin % Range Over the Past 10 Years
Min: 3.64  Med: 6.13 Max: 7.53
Current: 7.23
3.64
7.53
ROE % 16.12
UHS's ROE % is ranked higher than
73% of the 240 Companies
in the Global Medical Care industry.

( Industry Median: 9.89 vs. UHS: 16.12 )
Ranked among companies with meaningful ROE % only.
UHS' s ROE % Range Over the Past 10 Years
Min: 11.67  Med: 15.9 Max: 18.6
Current: 16.12
11.67
18.6
ROA % 7.24
UHS's ROA % is ranked higher than
68% of the 259 Companies
in the Global Medical Care industry.

( Industry Median: 4.66 vs. UHS: 7.24 )
Ranked among companies with meaningful ROA % only.
UHS' s ROA % Range Over the Past 10 Years
Min: 4.01  Med: 5.89 Max: 7.32
Current: 7.24
4.01
7.32
ROC (Joel Greenblatt) % 28.28
UHS's ROC (Joel Greenblatt) % is ranked higher than
62% of the 257 Companies
in the Global Medical Care industry.

( Industry Median: 21.13 vs. UHS: 28.28 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
UHS' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 15.97  Med: 23.03 Max: 28.88
Current: 28.28
15.97
28.88
3-Year Revenue Growth Rate 10.20
UHS's 3-Year Revenue Growth Rate is ranked higher than
57% of the 183 Companies
in the Global Medical Care industry.

( Industry Median: 8.50 vs. UHS: 10.20 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
UHS' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -4.2  Med: 10.4 Max: 19.4
Current: 10.2
-4.2
19.4
3-Year EBITDA Growth Rate 11.40
UHS's 3-Year EBITDA Growth Rate is ranked higher than
57% of the 161 Companies
in the Global Medical Care industry.

( Industry Median: 8.10 vs. UHS: 11.40 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
UHS' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -3.3  Med: 13.8 Max: 26.7
Current: 11.4
-3.3
26.7
3-Year EPS without NRI Growth Rate 11.60
UHS's 3-Year EPS without NRI Growth Rate is ranked higher than
57% of the 139 Companies
in the Global Medical Care industry.

( Industry Median: 8.40 vs. UHS: 11.60 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
UHS' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -11.3  Med: 20.5 Max: 73.8
Current: 11.6
-11.3
73.8
GuruFocus has detected 1 Warning Sign with Universal Health Services Inc $UHS.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» UHS's 30-Y Financials

Financials (Next Earnings Date: 2017-07-25 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q2 2016

UHS Guru Trades in Q2 2016

Ray Dalio 1,500 sh (New)
Lee Ainslie 2,768,938 sh (+186.48%)
Joel Greenblatt 334,501 sh (+100.72%)
Paul Tudor Jones 3,571 sh (+1.54%)
Vanguard Health Care Fund 3,939,340 sh (unchged)
Chris Davis Sold Out
Andreas Halvorsen Sold Out
John Paulson Sold Out
Ron Baron 195,584 sh (-1.05%)
Private Capital 121,825 sh (-13.32%)
RS Investment Management 184,694 sh (-18.86%)
Robert Olstein 24,000 sh (-29.41%)
Westport Asset Management 400,827 sh (-29.85%)
Jeremy Grantham 13,000 sh (-37.20%)
Jim Simons 108,100 sh (-49.72%)
Steven Cohen 2,700 sh (-86.36%)
» More
Q3 2016

UHS Guru Trades in Q3 2016

Jana Partners 1,273,646 sh (New)
Larry Robbins 950,390 sh (New)
Andreas Halvorsen 1,929,192 sh (New)
Jim Simons 248,900 sh (+130.25%)
Lee Ainslie 4,584,358 sh (+65.56%)
Robert Olstein 34,000 sh (+41.67%)
Vanguard Health Care Fund 3,939,340 sh (unchged)
Ray Dalio Sold Out
Jeremy Grantham Sold Out
Steven Cohen Sold Out
Private Capital 119,170 sh (-2.18%)
Ron Baron 189,684 sh (-3.02%)
Joel Greenblatt 295,558 sh (-11.64%)
Paul Tudor Jones 2,200 sh (-38.39%)
» More
Q4 2016

UHS Guru Trades in Q4 2016

Paul Tudor Jones 12,393 sh (+463.32%)
Larry Robbins 1,762,915 sh (+85.49%)
Robert Olstein 57,000 sh (+67.65%)
Jana Partners 2,051,970 sh (+61.11%)
Lee Ainslie 6,130,994 sh (+33.74%)
Vanguard Health Care Fund 4,527,240 sh (+14.92%)
Private Capital 109,139 sh (-8.42%)
Ron Baron 156,224 sh (-17.64%)
Joel Greenblatt 182,778 sh (-38.16%)
Andreas Halvorsen 350,693 sh (-81.82%)
Jim Simons 16,400 sh (-93.41%)
» More
Q1 2017

UHS Guru Trades in Q1 2017

Steven Cohen 108,830 sh (New)
Andreas Halvorsen 1,728,658 sh (+392.93%)
Jana Partners 2,449,017 sh (+19.35%)
Ron Baron 156,224 sh (unchged)
Jim Simons Sold Out
Joel Greenblatt Sold Out
Private Capital 107,870 sh (-1.16%)
Larry Robbins 1,714,464 sh (-2.75%)
Vanguard Health Care Fund 4,289,109 sh (-5.26%)
Lee Ainslie 4,952,724 sh (-19.22%)
Robert Olstein 41,000 sh (-28.07%)
Paul Tudor Jones 7,674 sh (-38.08%)
» More
» Details

Insider Trades

Latest Guru Trades with UHS

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Health Care Providers » Medical Care    NAICS: 622110    SIC: 8062
Compare:OTCPK:RMSYF, NYSE:DVA, NAS:WOOF, OTCPK:SKHCF, NYSE:EVHC, OTCPK:CAKFY, NYSE:MD, NYSE:HLS, NAS:ACHC, NYSE:CHE, NAS:LPNT, OTCPK:LTGHY, NAS:SCAI, NAS:AMED, NYSE:SEM, NYSE:THC, NYSE:AMN, NAS:TVTY, NAS:LHCG, NAS:SGRY » details
Traded in other countries:UHS.Germany, UHID.USA,
Headquarter Location:USA
Universal Health Services Inc through its subsidiaries is engaged in the business of owning and operating acute care hospitals, behavioral health centers, surgical hospitals, ambulatory surgery centers and radiation oncology centers.

Universal Health Services owns and operates acute care hospitals, behavior health centers, surgical hospitals, ambulatory surgery centers, and radiation oncology centers. The firm operates in two key segments: Acute Care Hospital Services and Behavioral Health Services. The Acute Care Hospital Services segment includes the firm's acute care hospitals, surgical hospitals, and surgery and oncology centers. Each segment contributes roughly half of the firm's overall revenue. Universal Health Services receives a significant portion of its net patient revenue from Medicare and Medicaid. The largest proportion of the firm's net patient revenue is paid by managed care organizations.

Guru Investment Theses on Universal Health Services Inc

Baron Funds Comments on Universal Health Services Inc. - Aug 18, 2015

Universal Health Services, Inc. (NYSE:UHS) is a leading operator of acute care hospitals, and it is also the country’s largest provider of behavioral health services. The company’s shares rose sharply in late-June in response to the U.S. Supreme Court’s decision to uphold a key provision of the Affordable Care Act (ACA), which has expanded insurance coverage to almost 13 million Americans. The court’s decision removes meaningful future legal challenges to the ACA, which has driven a meaningful increase in hospital utilization. This court decision came on the heels of solid quarterly earnings results. As the dominant acute care provider in some of the fastest growing markets in the U.S., we continue to like Universal’s positioning and prospects. We are particularly excited about the opportunity for its behavioral health business to gain more favorable reimbursement treatment for Medicaid patients.



From Baron Funds' second quarter commentary.



Check out Ron Baron latest stock trades

Top Ranked Articles about Universal Health Services Inc

Westport's Top 7 Transactions in 2nd Quarter Were Reductions Firm sells 30% of position in Universal Health Services
Westport Asset Management (Trades, Portfolio)’s top seven transactions in the second quarter were reductions of stakes in its portfolio. Read more...

Ratios

vs
industry
vs
history
PE Ratio 15.83
UHS's PE Ratio is ranked higher than
76% of the 196 Companies
in the Global Medical Care industry.

( Industry Median: 9999.00 vs. UHS: 15.83 )
Ranked among companies with meaningful PE Ratio only.
UHS' s PE Ratio Range Over the Past 10 Years
Min: 8.1  Med: 15.25 Max: 25.04
Current: 15.83
8.1
25.04
Forward PE Ratio 14.62
UHS's Forward PE Ratio is ranked higher than
78% of the 108 Companies
in the Global Medical Care industry.

( Industry Median: 18.73 vs. UHS: 14.62 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 15.83
UHS's PE Ratio without NRI is ranked higher than
78% of the 196 Companies
in the Global Medical Care industry.

( Industry Median: 28.00 vs. UHS: 15.83 )
Ranked among companies with meaningful PE Ratio without NRI only.
UHS' s PE Ratio without NRI Range Over the Past 10 Years
Min: 8.26  Med: 15.21 Max: 25.26
Current: 15.83
8.26
25.26
Price-to-Owner-Earnings 12.59
UHS's Price-to-Owner-Earnings is ranked higher than
78% of the 96 Companies
in the Global Medical Care industry.

( Industry Median: 27.48 vs. UHS: 12.59 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
UHS' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 7.55  Med: 15.84 Max: 412.27
Current: 12.59
7.55
412.27
PB Ratio 2.37
UHS's PB Ratio is ranked higher than
50% of the 238 Companies
in the Global Medical Care industry.

( Industry Median: 2.65 vs. UHS: 2.37 )
Ranked among companies with meaningful PB Ratio only.
UHS' s PB Ratio Range Over the Past 10 Years
Min: 1.01  Med: 2.14 Max: 3.54
Current: 2.37
1.01
3.54
PS Ratio 1.15
UHS's PS Ratio is ranked higher than
60% of the 238 Companies
in the Global Medical Care industry.

( Industry Median: 1.57 vs. UHS: 1.15 )
Ranked among companies with meaningful PS Ratio only.
UHS' s PS Ratio Range Over the Past 10 Years
Min: 0.33  Med: 0.79 Max: 1.68
Current: 1.15
0.33
1.68
Price-to-Free-Cash-Flow 14.97
UHS's Price-to-Free-Cash-Flow is ranked higher than
67% of the 106 Companies
in the Global Medical Care industry.

( Industry Median: 23.72 vs. UHS: 14.97 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
UHS' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 8.57  Med: 15.81 Max: 342.44
Current: 14.97
8.57
342.44
Price-to-Operating-Cash-Flow 8.77
UHS's Price-to-Operating-Cash-Flow is ranked higher than
71% of the 154 Companies
in the Global Medical Care industry.

( Industry Median: 14.15 vs. UHS: 8.77 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
UHS' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 3.2  Med: 8.48 Max: 24.67
Current: 8.77
3.2
24.67
EV-to-EBIT 11.97
UHS's EV-to-EBIT is ranked higher than
77% of the 292 Companies
in the Global Medical Care industry.

( Industry Median: 18.39 vs. UHS: 11.97 )
Ranked among companies with meaningful EV-to-EBIT only.
UHS' s EV-to-EBIT Range Over the Past 10 Years
Min: 6.2  Med: 11.9 Max: 26
Current: 11.97
6.2
26
EV-to-EBITDA 8.96
UHS's EV-to-EBITDA is ranked higher than
75% of the 306 Companies
in the Global Medical Care industry.

( Industry Median: 13.46 vs. UHS: 8.96 )
Ranked among companies with meaningful EV-to-EBITDA only.
UHS' s EV-to-EBITDA Range Over the Past 10 Years
Min: 4.3  Med: 8.6 Max: 12.2
Current: 8.96
4.3
12.2
PEG Ratio 1.93
UHS's PEG Ratio is ranked higher than
63% of the 94 Companies
in the Global Medical Care industry.

( Industry Median: 3.11 vs. UHS: 1.93 )
Ranked among companies with meaningful PEG Ratio only.
UHS' s PEG Ratio Range Over the Past 10 Years
Min: 0.35  Med: 1.13 Max: 7.27
Current: 1.93
0.35
7.27
Shiller PE Ratio 25.47
UHS's Shiller PE Ratio is ranked higher than
51% of the 45 Companies
in the Global Medical Care industry.

( Industry Median: 28.31 vs. UHS: 25.47 )
Ranked among companies with meaningful Shiller PE Ratio only.
UHS' s Shiller PE Ratio Range Over the Past 10 Years
Min: 10.2  Med: 21.82 Max: 40.68
Current: 25.47
10.2
40.68
Current Ratio 1.14
UHS's Current Ratio is ranked lower than
51% of the 244 Companies
in the Global Medical Care industry.

( Industry Median: 1.30 vs. UHS: 1.14 )
Ranked among companies with meaningful Current Ratio only.
UHS' s Current Ratio Range Over the Past 10 Years
Min: 0.95  Med: 1.41 Max: 1.98
Current: 1.14
0.95
1.98
Quick Ratio 1.06
UHS's Quick Ratio is ranked higher than
50% of the 244 Companies
in the Global Medical Care industry.

( Industry Median: 1.18 vs. UHS: 1.06 )
Ranked among companies with meaningful Quick Ratio only.
UHS' s Quick Ratio Range Over the Past 10 Years
Min: 0.82  Med: 1.3 Max: 1.78
Current: 1.06
0.82
1.78
Days Inventory 42.11
UHS's Days Inventory is ranked lower than
74% of the 192 Companies
in the Global Medical Care industry.

( Industry Median: 16.88 vs. UHS: 42.11 )
Ranked among companies with meaningful Days Inventory only.
UHS' s Days Inventory Range Over the Past 10 Years
Min: 9.58  Med: 42.75 Max: 45.46
Current: 42.11
9.58
45.46
Days Sales Outstanding 53.22
UHS's Days Sales Outstanding is ranked lower than
67% of the 209 Companies
in the Global Medical Care industry.

( Industry Median: 40.40 vs. UHS: 53.22 )
Ranked among companies with meaningful Days Sales Outstanding only.
UHS' s Days Sales Outstanding Range Over the Past 10 Years
Min: 42.28  Med: 53.19 Max: 62.41
Current: 53.22
42.28
62.41
Days Payable 152.30
UHS's Days Payable is ranked higher than
83% of the 162 Companies
in the Global Medical Care industry.

( Industry Median: 40.41 vs. UHS: 152.30 )
Ranked among companies with meaningful Days Payable only.
UHS' s Days Payable Range Over the Past 10 Years
Min: 24.51  Med: 117.93 Max: 155.6
Current: 152.3
24.51
155.6

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 0.34
UHS's Dividend Yield % is ranked lower than
96% of the 247 Companies
in the Global Medical Care industry.

( Industry Median: 1.57 vs. UHS: 0.34 )
Ranked among companies with meaningful Dividend Yield % only.
UHS' s Dividend Yield % Range Over the Past 10 Years
Min: 0.17  Med: 0.45 Max: 0.99
Current: 0.34
0.17
0.99
Dividend Payout Ratio 0.05
UHS's Dividend Payout Ratio is ranked higher than
99% of the 146 Companies
in the Global Medical Care industry.

( Industry Median: 0.41 vs. UHS: 0.05 )
Ranked among companies with meaningful Dividend Payout Ratio only.
UHS' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.04  Med: 0.06 Max: 0.1
Current: 0.05
0.04
0.1
3-Year Dividend Growth Rate 26.00
UHS's 3-Year Dividend Growth Rate is ranked higher than
74% of the 82 Companies
in the Global Medical Care industry.

( Industry Median: 11.70 vs. UHS: 26.00 )
Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
UHS' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: 0  Med: 0 Max: 58.7
Current: 26
0
58.7
Forward Dividend Yield % 0.34
UHS's Forward Dividend Yield % is ranked lower than
98% of the 240 Companies
in the Global Medical Care industry.

( Industry Median: 1.84 vs. UHS: 0.34 )
Ranked among companies with meaningful Forward Dividend Yield % only.
N/A
5-Year Yield-on-Cost % 0.79
UHS's 5-Year Yield-on-Cost % is ranked lower than
87% of the 311 Companies
in the Global Medical Care industry.

( Industry Median: 2.23 vs. UHS: 0.79 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
UHS' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.4  Med: 1.05 Max: 2.31
Current: 0.79
0.4
2.31
3-Year Average Share Buyback Ratio 0.60
UHS's 3-Year Average Share Buyback Ratio is ranked higher than
85% of the 130 Companies
in the Global Medical Care industry.

( Industry Median: -2.50 vs. UHS: 0.60 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
UHS' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -6.3  Med: 1.2 Max: 3.6
Current: 0.6
-6.3
3.6

Valuation & Return

vs
industry
vs
history
Price-to-Tangible-Book 11.83
UHS's Price-to-Tangible-Book is ranked lower than
94% of the 187 Companies
in the Global Medical Care industry.

( Industry Median: 3.76 vs. UHS: 11.83 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
UHS' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.84  Med: 3.98 Max: 317.57
Current: 11.83
0.84
317.57
Price-to-Intrinsic-Value-Projected-FCF 1.00
UHS's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
79% of the 89 Companies
in the Global Medical Care industry.

( Industry Median: 9999.00 vs. UHS: 1.00 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
UHS' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.72  Med: 1.17 Max: 33.96
Current: 1
0.72
33.96
Price-to-Intrinsic-Value-DCF (Earnings Based) 0.71
UHS's Price-to-Intrinsic-Value-DCF (Earnings Based) is ranked higher than
94% of the 32 Companies
in the Global Medical Care industry.

( Industry Median: 1.81 vs. UHS: 0.71 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only.
N/A
Price-to-Median-PS-Value 1.45
UHS's Price-to-Median-PS-Value is ranked lower than
79% of the 199 Companies
in the Global Medical Care industry.

( Industry Median: 1.04 vs. UHS: 1.45 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
UHS' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.11  Med: 0.95 Max: 2.08
Current: 1.45
0.11
2.08
Price-to-Peter-Lynch-Fair-Value 1.76
UHS's Price-to-Peter-Lynch-Fair-Value is ranked higher than
51% of the 47 Companies
in the Global Medical Care industry.

( Industry Median: 2.13 vs. UHS: 1.76 )
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
UHS' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0.4  Med: 1.39 Max: 3.54
Current: 1.76
0.4
3.54
Price-to-Graham-Number 2.89
UHS's Price-to-Graham-Number is ranked lower than
74% of the 123 Companies
in the Global Medical Care industry.

( Industry Median: 2.35 vs. UHS: 2.89 )
Ranked among companies with meaningful Price-to-Graham-Number only.
UHS' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 0.56  Med: 1.71 Max: 12.53
Current: 2.89
0.56
12.53
Earnings Yield (Greenblatt) % 8.35
UHS's Earnings Yield (Greenblatt) % is ranked higher than
80% of the 334 Companies
in the Global Medical Care industry.

( Industry Median: 4.98 vs. UHS: 8.35 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
UHS' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 3.8  Med: 8.4 Max: 16.1
Current: 8.35
3.8
16.1
Forward Rate of Return (Yacktman) % 14.53
UHS's Forward Rate of Return (Yacktman) % is ranked higher than
61% of the 119 Companies
in the Global Medical Care industry.

( Industry Median: 11.19 vs. UHS: 14.53 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
UHS' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 4.4  Med: 18.25 Max: 30.8
Current: 14.53
4.4
30.8

More Statistics

Revenue (TTM) (Mil) $9,929
EPS (TTM) $ 7.33
Beta0.90
Short Percentage of Float2.94%
52-Week Range $99.72 - 139.46
Shares Outstanding (Mil)96.69

Analyst Estimate

Dec17 Dec18 Dec19
Revenue (Mil $) 11,007 11,723 12,442
EPS ($) 7.94 8.74 9.45
EPS without NRI ($) 7.94 8.74 9.45
EPS Growth Rate
(Future 3Y To 5Y Estimate)
N/A
Dividends per Share ($) 0.20 0.20 0.20
» More Articles for UHS

Headlines

Articles On GuruFocus.com
Universal Health Services, Inc. To Present At The UBS Global Healthcare Conference May 16 2017 
Universal Health Services, Inc. To Present At The Bank Of America Merrill Lynch 2017 Healthcare Conf May 10 2017 
Universal Health Services, Inc. to Present at the Deutsche Bank 42nd Annual Healthcare Conference Apr 27 2017 
Universal Health Services, Inc. Announces Date For First Quarter 2017 Earnings Release And Conferenc Apr 11 2017 
DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Univers Feb 20 2017 
UNIVERSAL HEALTH 96 HOUR DEADLINE ALERT: APPROXIMATELY 96 HOURS REMAIN; FORMER LOUISIANA ATTORNEY GE Feb 18 2017 
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Unive Feb 13 2017 
LESS THAN ONE MONTH REMAINS FOR UNIVERSAL HEALTH SERVICES INVESTORS: Hagens Berman Reminds Universal Jan 24 2017 
UHS LOSS ALERT: Rosen Law Firm Reminds Universal Health Services, Inc. Investors of Important Deadli Jan 24 2017 
UHS INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Un Jan 23 2017 

More From Other Websites
Universal Health (UHS) Down 2% Since Earnings Report: Can It Rebound? May 26 2017
Universal Health Services stock drops 5% after report of FBI, Defense Department investigation May 24 2017
Universal Health Services shares slip on report of broader federal probe May 23 2017
Universal Health (UHS) Receives Rating Action from Moody's May 22 2017
Universal Health Services, Inc. -- Moody's Affirms Universal Health Services' Ba1 CFR; stable... May 18 2017
Universal Health Services, Inc. Announces Dividend May 17 2017
Universal Health Services, Inc. To Present At The UBS Global Healthcare Conference May 16 2017
Universal Health Services, Inc. breached its 50 day moving average in a Bearish Manner : UHS-US :... May 16 2017
Home Depot, Walmart — What to watch in the markets this week May 14 2017
Universal Health Services, Inc. To Present At The Bank Of America Merrill Lynch 2017 Healthcare... May 10 2017
Universal Health Services, Inc. – Value Analysis (NYSE:UHS) : May 4, 2017 May 04 2017
Hospital stocks care more about earnings than Trumpcare May 04 2017
Today's charts: Hospital stocks drop as House health care vote approaches May 04 2017
Controversial psychiatric chain still seeking to build Wilsonville hospital May 03 2017
Universal Health Services, Inc. breached its 50 day moving average in a Bullish Manner : UHS-US :... May 03 2017
Edited Transcript of UHS earnings conference call or presentation 26-Apr-17 1:00pm GMT Apr 28 2017
Universal Health Services, Inc. to Present at the Deutsche Bank 42nd Annual Healthcare Conference Apr 27 2017
Universal Health (UHS) Beats on Q1 Earnings, Misses Revenues Apr 26 2017
Universal Health Services (UHS) Reports Mixed Q1 Results Apr 25 2017
Universal Health Services posts 1Q profit Apr 25 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)